MEA Vascular Access Devices Market

Middle East And Africa Vascular Access Devices Market Size & Growth (2023 to 2028):

As per the research report, the size of the Middle East and Africa Vascular Access Devices Market is valued at USD 0.38 billion in 2023 and is expected to reach USD 0.51 billion by 2028 to grow at 5.90% CAGR during the forecast period 2023 to 2028.

Vascular access devices (VAD) are placed in large veins in the body. The VAD application is seen in patients suffering chronic illness or critical disorders, which require accessible and continuous medication ports of entry such as chemotherapy, end-stage kidney disorder, transplant patients, etc. According to the Clinical Kidney Journal data, the prevalence of chronic kidney disease in Africa was about 15% in 2018. VADs such as catheters are used for the transfusion of blood and other medical fluids.

According to statistics, in 2019, about 3500 patients were on the waiting list for a kidney transplant in the south of South Africa. This number is expected to increase over the forecast period, which will help drive the MEA VAD market during the projected period.

The rising prevalence of chronic diseases such as diabetes and breast cancer in Saudi Arabia has increased the usage of peripheral venous devices. There has been a significant rise in hospitalization, especially among the aging population; due to chronic disease complications and pandemic, the demand for VADs are rising because they are considered safe and relatively less painful than their counterparts. In addition, these devices are economical, easy to use, often included in reimbursements plans in most countries which are expected to drive the market during the analyzed period.

With growing technology in the field of VADs, the market in MEA is growing at a new high. For instance, grid mapping catheters can differentiate unhealthy from healthy tissues, and other substances are seen inside the heart valves. Many such developments are expected to create huge demand in the MEA region.

Regulatory authorities pose a major restraint for the Saudi Arabia peripheral venous access device market due to their stringent rules, which take a long approval time. Likewise, this factor affects other MEA regional markets negatively as well.

This research report on the Middle East & Africa Vascular Access Devices Market has been segmented and sub-segmented into the following categories:

By Type:

• Peripheral
• Central
• Accessories

By Application:

• Drug Administration
• Fluid & Nutrition Administration
• Blood Transfusion
• Diagnostics Testing

By End Users:

• Hospitals
• Clinics
• Ambulatory Care Centers
• Other End Users

By Country:

• KSA
• UAE
• Israel
• rest of GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• rest of MEA

Geographically, the Middle East market is the largest growth-contributing region during 2020 and is expected to maintain the same during the forecast period. The growing incidences of cardiovascular disorders, fast-growing lifestyle diseases, and the rise in the old age population are driving the market in the Middle East region.

The Saudi Arabia vascular access devices market is expected to influence the MEA market during the analyzed period. The Saudi Arabia VADs market is estimated to gather nearly $ 644 million in revenues by 2028, growing at a lucrative CAGR of 7.32%. This market growth is due to the rising prevalence of chronic diseases and well-developed healthcare facilities in the region.

The African vascular access devices market is estimated to reach $658 by 2028, growing at a high CAGR of 8% due to the high adoptability of technology-developed products, a high percentage of patients, and increased hospitalization rate in this region. In addition, the growing focus on improving healthcare in remote African countries will also fuel the market growth during the years to come.

The UAE vascular access devices market is estimated to grow at a CAGR of 4.5%. The UAE is the lucrative region after Saudi Arabia for gathering sales revenues. Other areas are also projected to expand and grow at a healthy growth rate due to the growing demand for VADs throughout the forecast period. Countries such as Qatar, Oman, Kuwait, Bahrain, and Egypt improve their healthcare facilities and support their aging population. These countries are to expect to expand their products to help raise market revenues.

KEY MARKET PLAYERS

Leading companies leading in the MEA Vascular Access Devices Market profiled in the report are Becton Dickinson and Company, C.R.Bard Inc, Smiths Medical, Inc., Teleflex Incorporated, B Braun Melsungen Ag, AngioDynamics, Terumo Corporation, Nipro Medical Corporation, Edwards Lifesciences Corporation, Ameco Medical, Romsons Scientific & Surgical Pvt. Ltd, and Prodimed.